Nygaard, Unni C.

Pre-natal Exposure to Perfluoroalkyl Substances May Be Associated with Altered Vaccine Antibody Levels and Immune-Related Health Outcomes in Early Childhood

Granum, B., Haug, L. S., Namork, E., Stølevik, S. B., Thomsen, C., Aaberge, I. S., van Loveren, H., Løvik, M., & Nygaard, U. C. (2013) · Journal of Immunotoxicology

Per- and polyfluoroalkyl substances researchImmunotoxicology and immune responses

Cited by 339

Perfluoroalkyl substances, airways infections, allergy and asthma related health outcomes–implications of gender, exposure period and study design

Kvalem, H. E., Nygaard, U. C., Lødrup Carlsen, K. C., Carlsen, K. H., Haug, L. S., & Granum, B. (2020) · Environment International

Per- and polyfluoroalkyl substances researchAsthma and respiratory diseases

Cited by 123

Exposure of Norwegian Toddlers to Perfluoroalkyl Substances (PFAS): The Association with Breastfeeding and Maternal PFAS Concentrations

Papadopoulou, E., Sabaredzovic, A., Namork, E., Nygaard, U. C., Granum, B., & Haug, L. S. (2016) · Environment International

Per- and polyfluoroalkyl substances researchToxic Organic Pollutants Impact

Cited by 100

Prenatal exposure to perfluoroalkyl substances modulates neonatal serum phospholipids, increasing risk of type 1 diabetes

McGlinchey, A., Sinioja, T., Lamichhane, S., Sen, P., Bodin, J., Siljander, H., Dickens, A. M., Geng, D., Carlsson, C., Duberg, D., et al. (2020) · Environment International

Per- and polyfluoroalkyl substances researchDiabetes and associated disorders

Cited by 61

Exposure to perfluoroundecanoic acid (PFUnDA) accelerates insulitis development in a mouse model of type 1 diabetes

Bodin, J., Groeng, E.-C., Andreassen, M., Dirven, H., & Nygaard, U. C. (2016) · Toxicology Reports

Per- and polyfluoroalkyl substances researchDiabetes and associated disorders

Cited by 51